[关键词]
[摘要]
目的：探讨正元芸生滴丸治疗非增生期糖尿病性黄斑水肿(diabetic macular edema，DME)的临床疗效。
方法：运用眼底荧光血管造影和光学相干断层扫描确诊非增生期DME患者共40例76眼，随机分为对照组和观察组，其中对照组20例40眼，给予常规治疗； 观察组20例36眼，在对照组基础上采用口服正元芸生滴丸进行治疗。于治疗后3mo检查黄斑区视网膜厚度和最佳矫正视力情况。
结果：对照组和观察组黄斑水肿消退率分别为13眼(32.5%)和24眼(66.7%)，差异均有统计学意义(P<0.05)。视力改善情况观察组优于对照组(P<0.01)。
结论：正元芸生滴丸对非增生期DME消退及视力提高方面有明显治疗作用。
[Key word]
[Abstract]
AIM: To observe the effect of Zhengyuanyunsheng dripping pills for non-proliferative diabetic macular edema(DME).
METHODS: Fundus fluorescein angiography(FFA)and optical coherence tomography(OCT)were used in diagnosis of non-proliferation in patients with DME in 40 cases(76 eyes). The cases were randomly assigned to the treatment group(20 cases, 40 eyes)and the control group(20 cases, 36 eyes). The cases in the treatment group were given conventional treatment, and those in the control group received Zhengyuanyunsheng dropping pill. After 3 months, macular retinal thickness and the best vision correction were recorded and compared.
RESULTS: Fade rate of macular edema in the control group and the treatment group were 13 eyes(32.5%)and 24 eyes(66.7%), the difference was statistically significant(P<0.05). The best vision correction in treatment group was better than that in the control group(P<0.01).
CONCLUSION: The Zhengyuanyunsheng dripping pills has obvious curative effect on macular edema and BCVA for the patients with diabetic retinopathy.
[中图分类号]
[基金项目]
吉林省科学技术厅资助项目(No.200705458)
